alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial  information extracted from the Balance
Sheet at July 31,  1997  (Unaudited)  and the  Statement  of Income for the Nine
Months Ended  October 31, 1997  (Unaudited)  and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              JAN-31-1998
<PERIOD-START>                                 FEB-01-1997
<PERIOD-END>                                   OCT-31-1997
<CASH>                                         17,387
<SECURITIES>                                   0
<RECEIVABLES>                                  15,760,271
<ALLOWANCES>                                   374,841
<INVENTORY>                                    0
<CURRENT-ASSETS>                               16,159,993
<PP&E>                                         2,109,953
<DEPRECIATION>                                 1,378,829
<TOTAL-ASSETS>                                 20,295,861
<CURRENT-LIABILITIES>                          3,978,638
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       80,141
<OTHER-SE>                                     11,895,288
<TOTAL-LIABILITY-AND-EQUITY>                   20,295,861
<SALES>                                        8,411,782
<TOTAL-REVENUES>                               8,411,782
<CGS>                                          4,406,778
<TOTAL-COSTS>                                  1,598,231
<OTHER-EXPENSES>                               46,719
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             608,245
<INCOME-PRETAX>                                1,751,809
<INCOME-TAX>                                   785,000
<INCOME-CONTINUING>                            966,809
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   966,809
<EPS-PRIMARY>                                  .16
<EPS-DILUTED>                                  .16
        


</TABLE>
#### Joseph Campanaro, as a Shareholder of TCI Construction Corporation, Suing in the Right of TCI Construction Corporation, Appellant, v Joseph Tribble et al., Respondents.

Order, Supreme Court, New York County (Harold Tompkins, J.), entered March 23, 1990, which, *inter alia,*denied a petition under Business Corporation Law § 619 to nullify a shareholder vote and election of officers held on January 10, 1990, unanimously affirmed to the extent appealed from, with costs.

The petition to challenge the outcome of the shareholder meeting necessarily involves the underlying issue of who rightfully exercised control over respondent TCI Construction Corporation. In the absence of documentary evidence of shareholdings, that question must await determination at trial, after completion of discovery. Concur—Rosenberger, J. P., Asch, Kassal, Wallach and Smith, JJ.
**EXHIBIT32**

** **

**CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

Inconnection with the Quarterly Report of Golden Minerals Company (the “Company”)on Form 10-Q for the quarter ended September 30, 2009 as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), theundersigned hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuantto § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) TheReport fully complies with the requirements of section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(2) Theinformation contained in the Report fairly presents, in all material respects,the financial condition and result of operations of the Company.

 

 
| /s/ Jeffrey G.  Clevenger                          |   |
|----------------------------------------------------|--------|
| Jeffrey G.  Clevenger                              |   |
| President and  Chief Executive Officer             |   |
| November 2,  2009                             |   |
|                                               |   |
|                                               |   |
| /s/ Robert P.  Vogels                              |   |
| Robert P. Vogels                                   |   |
| Senior Vice  President and Chief Financial Officer |   |
| November 2, 2009                              |   |

 

----
<TABLE> <S> <C>

<ARTICLE>                                   5
<MULTIPLIER>                                1
<CURRENCY>                       U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                 DEC-31-1998
<PERIOD-START>                    JAN-01-1998
<PERIOD-END>                      MAR-31-1998
<EXCHANGE-RATE>                             1
<CASH>                             12,140,802
<SECURITIES>                                0
<RECEIVABLES>                      27,980,501
<ALLOWANCES>                                0
<INVENTORY>                                 0
<CURRENT-ASSETS>                   53,787,916
<PP&E>                             14,855,921
<DEPRECIATION>                      3,824,060
<TOTAL-ASSETS>                    170,193,021
<CURRENT-LIABILITIES>              33,692,395
<BONDS>                                     0
<PREFERRED-MANDATORY>                       0
<PREFERRED>                                 0
<COMMON>                              135,028
<OTHER-SE>                         83,433,774
<TOTAL-LIABILITY-AND-EQUITY>      170,193,021
<SALES>                                     0
<TOTAL-REVENUES>                   61,179,791
<CGS>                                       0
<TOTAL-COSTS>                      56,795,430
<OTHER-EXPENSES>                            0
<LOSS-PROVISION>                            0
<INTEREST-EXPENSE>                    472,219
<INCOME-PRETAX>                     3,912,142
<INCOME-TAX>                        1,486,614
<INCOME-CONTINUING>                 2,425,528
<DISCONTINUED>                              0
<EXTRAORDINARY>                             0
<CHANGES>                                   0
<NET-INCOME>                        2,425,528
<EPS-PRIMARY>                            0.18
<EPS-DILUTED>                            0.15
        


</TABLE>
#### The People of the State of New York, Respondent, v Carlos Moquete, Appellant.

Judgment, Supreme Court, New York County (Joan Carey, J., at *Huntley/Mapp*hearing, trial and sentence), rendered July 30, 1987, convicting defendant, after a jury trial, of criminal possession of a controlled substance in the first and third degrees and sentencing him to concurrent indeterminate prison terms of from 15 years to life and from *8V2*to 25 years, unanimously affirmed.

Police officers assigned to the Drug Enforcement Task Force arranged a "buy-and-bust” operation on March 26, 1986 using a known confidential informant. A detective maintained surveillance over the informant. The informant met defendant and another person at a designated location; a bag containing two kilograms of cocaine was recovered from defendant’s car.

The hearing court correctly denied defendant’s motion to suppress the evidence since the information provided by the informant, which was verified by the detective’s observations, satisfied the two-pronged requirement of *Aguilar-Spinelli (Aguilar v Texas,*378 US 108; *Spinelli v United States,*393 US 410). This, combined with the detective’s observation of what he recognized as a kilo package of cocaine in defendant’s vehicle, provided probable cause for defendant’s arrest and the incidental search of his car *(People v McRay,*51 NY2d 594). The trial evidence was sufficient to establish beyond a reasonable doubt that the defendant knowingly possessed the cocaine *(People v Reisman,*29 NY2d 278, *cert denied*405 US 1041). Concur — Ross, J. P., Rosenberger, Kassal, Ellerin and Rubin, JJ.
NATIONAL DEFENSE UNIVERSITY
JOINT FORCES STAFF COLLEGE
NORFOLK, VA 23511-1702

8 January 2018

MEMORANDUM FROM MILITARY HUMAN RESOURCES OFFICE (MHRO)

SUBJECT: Billing Rates / Messing for JFSC Joint and Combined Warfighting School (JCWS),
Joint Professional Military Education (JPME) Phase II Students

REF: (a) Joint Travel Regulations (JTR)
(b) HQDA DCS G-3-5-7 message DTG R 281721Z AUG 17

1, In accordance with reference (a), effective 1 October 2017, the following rates apply for students
attending the Joint Forces Staff College (JFSC), JPME Phase II Course. Reference (b) provides
additional administrative guidance for U.S. Army personnel.

STUDENT LODGING:

- Students lodging on base at Navy Gateway Inns & Suites (NGIS) and the Navy Lodge are entitled
to 100% reimbursement of their lodging cost. Both the NGIS and Navy Lodge are considered
government quarters.

NOTE: Per the JTR, students directed to commercial lodging off base at time of NGIS check in
(excluding lodging made in arrangement with the Navy-Lodge by NGIS) will be required to obtain
a non-availability confirmation number from NGIS (not Naval Station Norfolk) along with the
phone number and name of the providing lodging rep to be submitted with travel claims for
lodging reimbursement.

- Students lodging off-base in independently procured commercial lodging (i.e., not obtained via the
Sources above) are subject to a “Flat Rate” Per Diem which shall not exceed $69.75 per day, seven
days per week ($69.75 is 75% of the maxium lodging rate for Norfolk, VA for a TDY in length of
31-180 days).

STUDENT MESSING: Government Messing Facilities are not available for students at JFSC. The
JTR maximum rate for the meal and incidental expense (M&IE) for Norfolk, VA is $51.00; however, due
to the length of JPME II, the 75% flat rate applies to all students whether lodging on or off-base:

- $51.00 per day @ the 75% flat rate = $38.25 (applies to TDYs in length of 31-180 days).

2. Points of Contact for this memo are JFSC-MHRO Service Representatives who can be reached at these
numbers: (USAF) DSN 646-6131; (USN/USMC/USCG) DSN 646-6091; and (USA) DSN 646-6158.
Commercial telephone prefix for all numbers is (757) 443-XXXX.

3. This memorandum supersedes all previous JFSC-MHRO billing rate memorandums and remains in
effect until superseded.

~ BELL
LT, U.S. Navy
Chief, Military Human Resources Office

Attachments:
Copy of Ref (b)
<TABLE> <S> <C>

<ARTICLE>                     5
    <CIK>                     0000943322
    <NAME>                    TRUMP HOTELS & CASINO RESORTS HOLDINGS, L.P.
<MULTIPLIER>                                     1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                         146,300
<SECURITIES>                                         0
<RECEIVABLES>                                   84,824
<ALLOWANCES>                                    17,453
<INVENTORY>                                     12,333
<CURRENT-ASSETS>                               255,665
<PP&E>                                       2,294,486
<DEPRECIATION>                                 277,112
<TOTAL-ASSETS>                               2,473,304
<CURRENT-LIABILITIES>                          228,071
<BONDS>                                      1,624,570
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     521,460
<TOTAL-LIABILITY-AND-EQUITY>                 2,473,304
<SALES>                                      1,085,862
<TOTAL-REVENUES>                             1,226,082
<CGS>                                                0
<TOTAL-COSTS>                                  681,964 <F1>
<OTHER-EXPENSES>                               269,759 <F2>
<LOSS-PROVISION>                                 6,393
<INTEREST-EXPENSE>                             157,835
<INCOME-PRETAX>                                (21,959)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (21,959)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (21,959)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1> Includes gaming, lodging, food & beverage and other
<F2> Includes general & administration and depreciation & amortization
</FN>
        


</TABLE>
Union Calendar No. 153

103D CONGRESS

1ST SESSION H. J. RES. 228

[Report No. 103–279]

JOINT RESOLUTION

To approve the extension of nondiscriminatory

treatment with respect to the products of Romania.

OCTOBER 7, 1993

Committed to the Committee of the Whole House on the

State of the Union and ordered to be printed
IB

Union Calendar No. 153

103D CONGRESS

1ST SESSION H. J. RES. 228

[Report No. 103–279]

To approve the extension of nondiscriminatory treatment with respect to

the products of Romania.

IN THE HOUSE OF REPRESENTATIVES

JULY 13, 1993

Mr. GEPHARDT (for himself and Mr. MICHEL) (both by request) submitted

the following joint resolution; which was referred to the Committee on

Ways and Means

OCTOBER 7, 1993

Committed to the Committee of the Whole House on the State of the Union

and ordered to be printed

JOINT RESOLUTION

To approve the extension of nondiscriminatory treatment

with respect to the products of Romania.

1 Resolved by the Senate and House of Representatives

2 of the United States of America in Congress assembled,

3 That the Congress approves the extension of nondiscrim4 inatory treatment with respect to the products of Romania
2

•HJ 228 RH

1 transmitted by the President to the Congress on July 2,

2 1993.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

Part C (Centers for Disease Control and Prevention) of the Statement of Organizations, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 65 FR 68144, dated November 14, 2000) is amended to revise the functional statement of the Division for AIDS, STD, and TB Laboratory Research (DASTLR), National Center of Infections (NCID).

Section C-B, Organization and Functions, is hereby amended as follows: 

Delete the functional statement for the Division of AIDS, STD and TB Laboratory Research (HCRN) and insert the following:

*Division of AIDS, STD and TB Laboratory Research (HCRN).*                    (1) Develops and evaluates laboratory methods and procedures for the diagnosis and characterization of infections caused by human immunodeficiency virus (HIV) and other retroviruses, other sexually transmitted diseases (STDs), and mycobacteria including                     *Mycobacterium tuberculosis;*                     (2) provides laboratory support for the surveillance, epidemiologic, and clinical activities of the National Center for HIV, STD, and TB Prevention (NCHSTP); (3) conducts applied research on the pathogenesis of and the immune mechanisms that occur in microbial infections; (4) conducts laboratory studies of hemophilia and other coagulating disorders; (5) provides reference laboratory services and assists in standardizing and providing laboratory reagents; (6) serves as a World Health Organization Collaborating Center; (7) conducts epidemiologic studies of HIV-infected and uninfected persons with hemophilia and their families; (8) assists in designing, implementing, and evaluating prevention and counseling programs for HIV-infected persons with hemophilia and their families; and (9) coordinates research on opportunistic infections occurring in HIV-infected persons.                

Dated: November 15, 2000.

Jeffrey P. Koplan,

Director.

[FR Doc. 00-30217 Filed 11-27-00; 8:45 am]

BILLING CODE 4160-18-M
<PAGE>

EXHIBIT 32.1

          Certification Pursuant to 18 U.S.C. Section 1350, As Adopted
            Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

I, David Lieberman, the Principal Executive Officer and Principal Financial
Officer of Advanced Plant Pharmaceuticals, Inc. (the "Company"), certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section
1350, that to the best of my knowledge:

(1)      the Quarterly Report on Form 10-QSB of the Company for the fiscal
         quarter ended September 30, 2003 (the "Report") fully complies with the
         requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act
         of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)      the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.


Date: November 18, 2003



/s/ David Lieberman
-------------------
David Lieberman
Chief Executive Officer
Principal Financial Officer
Exhibit
32



CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,

AS
ADOPTED PURSUANT TO

SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002



In
connection with the Annual Report on Form 10-K of OncoCyte Corporation (the “Company”)
for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),
we, William Annett, Chief Executive Officer, and Mitchell Levine, Chief Financial
Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:



1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and



2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



Date:
April 30, 2018



|/s/
    William Annett      | 
|--------------------------- | 
|William
    Annett          | 
|Chief
    Executive Officer | 
|                            | 
|/s/
    Mitchell Levine     | 
|Mitchell
    Levine         | 
|Chief
    Financial Officer |
I

103D CONGRESS

1ST SESSION H. R. 1249

To permit Members of the House of Representatives to use their unspent

official allowances for college scholarships for residents of their congressional districts and for reduction of the national debt.

IN THE HOUSE OF REPRESENTATIVES

MARCH 9, 1993

Mr. BARTLETT of Maryland (for himself, Mr. ARMEY, Mr. BLUTE, Mr.

BONILLA, Mr. BUYER, Mr. COX, Mr. DIAZ-BALART, Mr. DORNAN, Mr.

EMERSON, Mr. EVERETT, Mr. GILCREST, Mr. GINGRICH, Mr. GREENWOOD, Mr. HOKE, Mr. HUNTER, Mrs. JOHNSON of Connecticut, Mr.

MCKEON, Mrs. MORELLA, Mr. POMBO, Mr. QUINN, Mr. HASTINGS, and

Mrs. MALONEY) introduced the following bill; which was referred to the

Committee on House Administration

A BILL

To permit Members of the House of Representatives to use

their unspent official allowances for college scholarships

for residents of their congressional districts and for reduction of the national debt.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

•HR 1249 IH

1 SECTION 1. UNSPENT AMOUNTS FROM ALLOWANCES OF

2 MEMBERS OF THE HOUSE OF REPRESENTA3 TIVES TO BE AVAILABLE FOR COLLEGE

4 SCHOLARSHIPS AND NATIONAL DEBT REDUC5 TION.

6 Notwithstanding any other provision of law, to the

7 extent that an allowance of a Member of the House of

8 Representatives is not otherwise used for a purpose speci9 fied by law or other authority, such allowance shall be

10 available to the Member—

11 (1) for college scholarships for residents of the

12 congressional district of the Member; and

13 (2) for reduction of the national debt.

14 SEC. 2. DEFINITIONS.

15 As used in this Act—

16 (1) the term ‘‘Member of the House of Rep17 resentatives’’ means a Representative in, or a Dele18 gate or Resident Commissioner to, the Congress;

19 and

20 (2) the term ‘‘allowance’’ means, with respect

21 to a Member of the House of Representatives, the

22 official expenses allowance, the clerk hire allowance,

23 the official mail allowance, or any other official al24 lowance of the Member.

Æ
#### Ram P. Manwani, Appellant, v Donald V. Reuter et al., Respondents.

Order, Supreme Court, New York County (William McCooe, J.), entered on June 19, 1990, which denied plaintiffs motion for an order staying arbitration and granted defendant’s cross motion for an order compelling arbitration, unanimously affirmed, without costs.

Plaintiff customer signed an agreement to arbitrate all claims with his stockbrokers except those arising under the Federal securities laws. To the extent plaintiff contends that he has raised such a claim, and that accordingly arbitration must be stayed, we observe that no such claim was raised in the verified complaint, nor has plaintiff sought leave to amend.

We decline to review plaintiff’s claim, raised for the first time on appeal, that there was fraud in the inducement to enter into the arbitration agreement. In passing, we note that the argument is without merit, being based solely on allegations that unrelated portions of an alleged oral agreement were breached *(see, Briefstein v Rotondo Constr. Co.,*8 AD2d 349).

We have reviewed the plaintiffs other arguments, and find them to be without merit. Concur—Ross, J. P., Carro, Asch, Wallach and Smith, JJ.